Vyvanse Gets Nod for ADHD

Physicians soon will have the option of prescribing a stimulant prodrug for the treatment of attention-deficit hyperactivity disorder. The Food and Drug Administration has approved Vyvanse (lisdexamfetamine dimesylate).